|
Hepatitis A
What
is hepatitis A?
| Hepatitis
A is a liver disease caused by the hepatitis A virus (HAV).
The disease is fairly common; several hundred cases are
reported each year in Wisconsin. |
Who gets hepatitis A?
| Hepatitis
A can affect anyone. Those more likely to get HAV include: |
|
|
persons
who share a household or have sexual contact with someone
who has hepatitis A |
|
|
men
who have sex with men |
|
|
persons
who use street drugs |
|
|
children
and employees in child care centers where a child or an
employee has hepatitis A |
|
|
travelers
to where hepatitis A is common |
|
|
persons with clotting factor disorders who receive factor
concentrates |
|
|
residents
and staff of institutions for developmentally disabled
persons when a resident or an employee has hepatitis A |
|
|
workers
who handle HAV-infected animals or work with HAV in a
research laboratory setting |
How
is hepatitis A transmitted?
HAV
is found in the stool of persons with hepatitis A. HAV
is spread from person to person by putting something in
the mouth that has been contaminated with the stool of
a person with hepatitis A. This type of transmission is
called "fecal-oral." For this reason, the virus
is more easily spread in areas where there are poor sanitary
conditions or where good personal hygiene is not observed.
If
careful hand washing with soap is not done, the virus
can then be carried on an infected person's hands. From
there, the virus can be spread to others by direct contact,
or by consuming food or drink that has been handled by
that infected individual. Because the virus is passed
in the stool, children with hepatitis A who are not toilet
trained can be an important source of the infection. Most
infections result from contact with a household member
or sex partner who has hepatitis A. Casual contact, as
in the usual office, factory, or school setting, does
not spread the virus. |
What
are the signs and symptoms of hepatitis A?
People
with hepatitis A may not have any signs or symptoms of
the disease.
If
symptoms are present, they usually occur abruptly and
may include: |
|
|
fever |
|
|
tiredness |
|
|
loss
of appetite |
|
|
nausea |
|
|
abdominal
discomfort |
|
|
dark
urine |
|
|
jaundice
(yellowing of the skin and eyes) |
Symptoms
usually last less than 2 months; a few persons are ill
for as long as 6 months. The average incubation period
for hepatitis A is 28 days (range: 15-50 days).
The disease is rarely fatal and most people recover without
any complications after several weeks. Infants and young
children tend to have very mild or no symptoms, and are
much less likely to develop jaundice than are older children
and adults. Persons who have pre-existing liver problems,
especially those who have hepatitis
C, can become extremely ill if they contract hepatitis
A. |
For
how long is an infected person able to spread the virus?
| A
person can spread HAV about two weeks before the symptoms
appear and for about one week after symptoms start. Persons
with no symptoms can still spread the virus. This often
happens with young children who unknowingly spread HAV
to older children and adults. |
Does
past infection with hepatitis A make a person immune?
| Yes.
Recovering from the disease produces lifelong immunity
from future HAV infection. Once a person recovers from
hepatitis A, he or she will never get it again. |
What
is the treatment for hepatitis A?
| Symptoms
usually appear 2-3 months after exposure (range: 1 ½-
6 months). |
How
can hepatitis A be prevented?
The
single most effective way to prevent the spread of the
hepatitis A virus is careful hand washing after using
the toilet, after diapering children, and prior to handling
food. The routine use of good hygiene is important because
a person with hepatitis A can be infectious to others
for about two weeks before they even know they are sick.
In addition, infected people should not handle foods during
the contagious period.
A
vaccine to prevent hepatitis A is available, but should
be given at least four weeks before potential exposure
takes place. Therefore, its use is currently limited to
persons whose activities are likely to put them at risk
of exposure to the hepatitis A virus in the future, such
as travelers to countries where the infection is prevalent.
Other groups for whom the vaccine is recommended or may
be beneficial include: |
|
|
persons
with chronic liver disease (including those who have hepatitis
C) |
|
|
persons
who have blood clotting-factor disorders |
|
|
sexually
active men who have sex with men |
|
|
persons
who work or reside in institutions for the developmentally
challenged |
|
|
persons
who use street drugs |
|
|
persons
living in communities which have very high levels of hepatitis
A and which are subject to periodic community-wide epidemics
of the disease |
| Vaccination
consists of two injections, given six to twelve months
apart. The initial dose will provide immunity to hepatitis
A beginning in about four weeks and lasting about one
year. The second dose provides long term immunity, which
lasts for years and perhaps is even life-long. |
Sources:
CDC - Division of Viral Hepatitis
Wisconsin Division of Public Health - Bureau of Communicable
Diseases
If
you don't find the information you are looking for on this
website, the
Wisconsin HIV, STD, and Hepatitis C Information & Referral
Center
hotline can provide information about STDs.
Please call us toll free in Wisconsin
1-800-334-2437
Or call CDC INFO at
1-800-232-4636
Disclaimer
| HIV/AIDS
Content Notice
| Site
Map |
|

|